Peripheral interleukin-1β levels are elevated in chronic tension-type headache patients

Pain Research and Management

Volumn 18, Issue 6, 2013, Pages 301-306

  Della Vedova, Chris ^a   Cathcart, Stuart ^b   Dohnalek, Alan ^a   Lee, Vanessa ^a   Hutchinson, Mark R ^c   Immink, Maarten A ^a   Hayball, John ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chronic tension type headache; Genetics; Inflammation; Interleukin 18; Interleukin 1

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC TENSION HEADACHE; CONTROLLED STUDY; CYTOKINE BLOOD LEVEL; CYTOMETRIC BEAD ARRAY; CYTOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HEREDITY; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOPATHOGENESIS; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TENSION-TYPE HEADACHE;

EID: 84894461503     PISSN: 12036765     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/796161     Document Type: Article

References (38)

1. Zagami AS. Chronic tension-type headache. CNS Drugs 1995;4:90-98.
2. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998;279:381-3.
3. Fumal A, Schoenen J. Tension-type headache: Current research and clinical management. Lancet Neurol 2008;7:70-83.
4. Langemark M, Bach FW, Jensen TS, Olesen J. Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch Neurol 1993;50:1061-4.
5. Ailani J. Chronic tension-type headache. Curr Pain Headache Rep 2009;13:479-83.
6. Koçer A, Koçer E, Memişoǧullari R, Domaç FM, Yüksel H. Interleukin-6 levels in tension headache patients. Clin J Pain 2010;26:690-3.
7. Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1beta sensors. J Neurosci 2008;28:14062-73.
8. Schaible HG, von Banchet GS, Boettger MK, et al. The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci 2010;1193:60-9.
9. Ohtori S, Takahashi K, Moriya H, Myers RR. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: Studies in murine DRG and spinal cord. Spine (Phila Pa 1976), 2004;29:1082-8.
10. Samad TA, Wang H, Broom DC, Woolf CJ. Central neuroimmune interactions after peripheral inflammation: Interleukin1-b potentiates synaptic transmission in the spinal cord. Proc Soc Neurosci 2004;34:511-7.
11. Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005;25:3219-28.
12. Sperlágh B, Baranyi M, Haskó G, Vizi ES. Potent effect of interleukin-1 beta to evoke ATP and adenosine release from rat hippocampal slices. J Neuroimmunol 2004;151:33-9.
13. Hucho T, Levine JD. Signaling pathways in sensitization: Toward a nociceptor cell biology. Neuron 2007;55:365-76.
14. Edwards RR, Kronfli T, Haythornthwaite JA, McGuire L, Page GG. Association of catastrophizing with interleukin-6 responses to acute pain. Pain 2008;140:135-44.
15. Hutchinson MR, La Vincente SF, Somogyi AA. In vitro opioid induced proliferation of peripheral blood immune cells correlates with in vivo cold pressor pain tolerance in humans: A biological marker of pain tolerance. Pain 2004;110:751-5.
16. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361:184-7.
17. International Headache Society, The International Classification of Headache Disorders: 2nd Edition (ICHD II). Cephalalgia (Supplement) 2004;24:9-160.
18. Cathcart S, Winefield AH, Lushington K, Rolan P. Noxious inhibition of temporal summation is impaired in chronic tension-type headache. Headache 2010;50:403-12.
19. Lovibond SH, Lovibond PF. Manual for the Depression Anxiety Stress Scales, 2nd edn. 1995, Sydney: Psychology Foundation.
20. Cathcart S, Pritchard D. Relationships between arousal-related moods and episodic tension-type headache: A biopsychological study. Headache 1998;38:214-21.
21. Liu L, Hutchinson MR, White JM, Somogyi AA, Coller JK. Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence. Pharmacogenet Genomics 2009;19:869-76.
22. Backonja MM, Coe CL, Muller DA, Schell K. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol 2008;195:157-63.
23. Uçeyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthrit Rheum 2006;54:2656-64.
24. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: A maladaptive response of the nervous system to damage. Ann Rev Neurosci 2009;32:1-32.
25. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005;6:521-32.
26. Perini F, D'Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache 2005;45:926-31.
27. Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006;46:200-7.
28. Neeb L, Hellen P, Boehnke C, et al. IL-1beta stimulates COX-2 dependent PGE(2) synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One 2011;6:e17360.
29. de Tommaso M, Ceci E, Pica C, et al. Serum levels of N-acetylaspartate in migraine and tension-type headache. J Headache Pain 2012;13:389-94.
30. Lionetto L, Capi M, Vignaroli G, Negro A, Martelletti P. Deciphering the task of N-acetyl aspartate in migraine. Exp Rev Neurotherapeut 2012;12:1057-9.
31. Nakanishi K, Yoshimoto T, Tsutsi H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12:53-72.
32. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. IL-1beta processing in host defense: Beyond the inflammasomes. PLoS Pathog 2010;6:e1000661.
33. Russell MB, Levi N, Kaprio J. Genetics of tension-type headache: A population based twin study. Am J Med Genet B Neuropsychiatr Genet 2007;144B:982-6.
34. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W. Genetic architecture of human pain perception. Trends Genet 2007;23:605-13.
35. Baune BT, Dannlowski U, Domschke K, et al. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 2010;67:543-9.
36. Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Interleukin-1 beta gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 2003;107:74-7.
37. Guimarães AL, de Sá AR, Victoria JM, de Fátima Correia-Silva J, Gomez MV, Gomez RS. Interleukin-1beta and serotonin transporter gene polymorphisms in burning mouth syndrome patients. J Pain 2006;7:654-8.
38. Ashina S, Lyngberg A, Jensen R. Headache characteristics and chronification of migraine and tension-type headache: A population-based study. Cephalalgia 2010;30:943-52.